scispace - formally typeset
N

Nicolas Duverger

Researcher at Aventis Pharma

Publications -  13
Citations -  2101

Nicolas Duverger is an academic researcher from Aventis Pharma. The author has contributed to research in topics: Tangier disease & ATP Binding Cassette Transporter 1. The author has an hindex of 10, co-authored 13 publications receiving 2026 citations.

Papers
More filters
Journal Article

PPAR alpha and PPAR gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABC-1 pathway.

TL;DR: A regulatory role is identified for PPAR-alpha andPPAR-gamma in the first steps of the reverse-cholesterol-transport pathway through the activation of ABCA1-mediated cholesterol efflux in human macrophages.
Journal ArticleDOI

Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.

TL;DR: Treatment of human primary hepatocytes with fenofibric acid and gemfibrozil provoked an 83 and 50% increase in apo A-I secretion and mRNA levels, respectively, supporting that a direct action of fibrates on liver human apo B-I production leads to the observed increase in plasma apo C4 and HDL-cholesterol.
Journal ArticleDOI

Characterization of the ABCA transporter subfamily: identification of prokaryotic and eukaryotic members, phylogeny and topology.

TL;DR: An alignment of the mammalian ABCA transporters enabled the identification of sequence segments, specific to the ABCA subfamily, which were used as queries to search for eukaryotic and prokaryotic homologues.
Journal ArticleDOI

The ABCA1 transporter functions on the basolateral surface of hepatocytes

TL;DR: Findings suggest an important role for hepatocyte basolateral membrane ABCA1 in the regulation of the levels of intracellular hepatic cholesterol, as well as plasma HDL.